MTIM
DNMR.WS

Marathon Trading Investment Management’s Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class DNMR.WS Stock Holding History

Marathon Trading Investment Management’s Portfolio DNMR.WS Stock Details DNMR.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-43,300
Closed -$1.1M – 466
2021
Q1 		$1.1M Buy
+43,300
New +$1.09M 0.1% 122

Marathon Trading Investment Management's DNMR.WS Position: Q2 2021 in Review

Marathon Trading Investment Management sold out of Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class (DNMR.WS) in Q2 2021, closing a stake of 43,300 shares — an estimated $1.1M sold.

Marathon Trading Investment Management first reported a position in DNMR.WS in Q1 2021 and held it in 1 quarter. The position peaked at $1.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold DNMR.WS as of Q2 2021.

  • Marathon Trading Investment Management reported no remaining Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class position as of Q2 2021 after selling out during the quarter.
  • Marathon Trading Investment Management sold 43,300 Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class shares in Q2 2021, an estimated $1.1M.
  • Marathon Trading Investment Management first reported a position in Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class in Q1 2021 and held it in 1 quarter.
  • Marathon Trading Investment Management's Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class position peaked at $1.1M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Danimer Scientific, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class as of Q2 2021.

Based on Marathon Trading Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.